Summary:
- This article discusses a new study that has found a connection between the use of certain antidepressant medications and an increased risk of developing type 2 diabetes.
- The study analyzed data from over 200,000 adults and found that those who took selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) had a higher likelihood of being diagnosed with type 2 diabetes compared to those who did not take these medications.
- The researchers suggest that the findings highlight the importance of closely monitoring the potential metabolic side effects of antidepressant medications, especially in individuals who may be at a higher risk of developing type 2 diabetes.